Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Polyfunctionality and breadth of HIV-1 antibodies are associated with delayed disease progression.
Grobben M, Bakker M, Schriek AI, Levels LJJ, Umotoy JC, Tejjani K, van Breemen MJ, Lin RN, de Taeye SW, Ozorowski G, Kootstra NA, Ward AB, Kent SJ, Hogarth PM, Wines BD, Sanders RW, Chung AW, van Gils MJ. Grobben M, et al. Among authors: tejjani k. PLoS Pathog. 2024 Dec 11;20(12):e1012739. doi: 10.1371/journal.ppat.1012739. eCollection 2024 Dec. PLoS Pathog. 2024. PMID: 39661636 Free PMC article.
Primary SARS-CoV-2 variant of concern infections elicit broad antibody Fc-mediated effector functions and memory B cell responses.
van der Straten K, Guerra D, Kerster G, Claireaux M, Grobben M, Schriek AI, Boyd A, van Rijswijk J, Tejjani K, Eggink D, Beaumont T, de Taeye SW, de Bree GJ, Sanders RW, van Gils MJ. van der Straten K, et al. Among authors: tejjani k. PLoS Pathog. 2024 Aug 15;20(8):e1012453. doi: 10.1371/journal.ppat.1012453. eCollection 2024 Aug. PLoS Pathog. 2024. PMID: 39146376 Free PMC article.
Similar Limited Protection Against Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Infection in Vaccinated Individuals With HIV and Comparable Controls.
Verburgh ML, Boyd A, Schim van der Loeff MF, Bakker M, Wit FWNM, van der Valk M, Grobben M, van Pul L, Tejjani K, van Rijswijk J, van Gils MJ, Kootstra NA, van der Hoek L, Reiss P; AGEhIV Cohort Study. Verburgh ML, et al. Among authors: tejjani k. Open Forum Infect Dis. 2024 Jul 8;11(7):ofae380. doi: 10.1093/ofid/ofae380. eCollection 2024 Jul. Open Forum Infect Dis. 2024. PMID: 39070044 Free PMC article.
Distinct groups of autoantigens as drivers of ocular adnexal MALT lymphoma pathogenesis.
Bende RJ, Donner N, Wormhoudt TA, Beentjes A, Scantlebery A, Grobben M, Tejjani K, Chandler F, Sikkema RS, Langerak AW, Guikema JE, van Noesel CJ. Bende RJ, et al. Among authors: tejjani k. Life Sci Alliance. 2024 Jul 8;7(9):e202402841. doi: 10.26508/lsa.202402841. Print 2024 Sep. Life Sci Alliance. 2024. PMID: 38977312 Free PMC article.
A spike virosome vaccine induces pan-sarbecovirus antibody responses in mice.
Brinkkemper M, Poniman M, Siteur-van Rijnstra E, Iddouch WA, Bijl TPL, Guerra D, Tejjani K, Grobben M, Bhoelan F, Bemelman D, Kempers R, van Gils MJ, Sliepen K, Stegmann T, van der Velden YU, Sanders RW. Brinkkemper M, et al. Among authors: tejjani k. iScience. 2024 Apr 10;27(5):109719. doi: 10.1016/j.isci.2024.109719. eCollection 2024 May 17. iScience. 2024. PMID: 38706848 Free PMC article.
Immunogenicity of COVID-19 booster vaccination in IEI patients and their one year clinical follow-up after start of the COVID-19 vaccination program.
van Leeuwen LPM, Grobben M, GeurtsvanKessel CH, Ellerbroek PM, de Bree GJ, Potjewijd J, Rutgers A, Jolink H, van de Veerdonk FL, van Gils MJ, de Vries RD, Dalm VASH; VACOPID Research Group. van Leeuwen LPM, et al. Front Immunol. 2024 Apr 18;15:1390022. doi: 10.3389/fimmu.2024.1390022. eCollection 2024. Front Immunol. 2024. PMID: 38698851 Free PMC article.
The Impact of First-Time SARS-CoV-2 Infection on Human Anelloviruses.
Timmerman AL, Commandeur L, Deijs M, Burggraaff MGJM, Lavell AHA, van der Straten K, Tejjani K, van Rijswijk J, van Gils MJ, Sikkens JJ, Bomers MK, van der Hoek L. Timmerman AL, et al. Among authors: tejjani k. Viruses. 2024 Jan 9;16(1):99. doi: 10.3390/v16010099. Viruses. 2024. PMID: 38257799 Free PMC article.
Into the Dark Serum Proteome: Personalized Features of IgG1 and IgA1 Repertoires in Severe COVID-19 Patients.
Bondt A, Hoek M, Dingess K, Tamara S, de Graaf B, Peng W, den Boer MA, Damen M, Zwart C, Barendregt A, van Rijswijck DMH, Schulte D, Grobben M, Tejjani K, van Rijswijk J, Völlmy F, Snijder J, Fortini F, Papi A, Volta CA, Campo G, Contoli M, van Gils MJ, Spadaro S, Rizzo P, Heck AJR. Bondt A, et al. Among authors: tejjani k. Mol Cell Proteomics. 2024 Jan;23(1):100690. doi: 10.1016/j.mcpro.2023.100690. Epub 2023 Dec 6. Mol Cell Proteomics. 2024. PMID: 38065436 Free PMC article.
Immune Responses 6 Months After mRNA-1273 COVID-19 Vaccination and the Effect of a Third Vaccination in Patients with Inborn Errors of Immunity.
van Leeuwen LPM, Grobben M, GeurtsvanKessel CH, Ellerbroek PM, de Bree GJ, Potjewijd J, Rutgers A, Jolink H, van de Veerdonk FL, van Gils MJ, de Vries RD, Dalm VASH; VACOPID Research Group. van Leeuwen LPM, et al. J Clin Immunol. 2023 Aug;43(6):1104-1117. doi: 10.1007/s10875-023-01514-7. Epub 2023 May 26. J Clin Immunol. 2023. PMID: 37231290 Free PMC article.
Robust Vaccine-Induced as Well as Hybrid B- and T-Cell Immunity across SARS-CoV-2 Vaccine Platforms in People with HIV.
Verburgh ML, van Pul L, Grobben M, Boyd A, Wit FWNM, van Nuenen AC, van Dort KA, Tejjani K, van Rijswijk J, Bakker M, van der Hoek L, Schim van der Loeff MF, van der Valk M, van Gils MJ, Kootstra NA, Reiss P. Verburgh ML, et al. Among authors: tejjani k. Microbiol Spectr. 2023 Jun 15;11(3):e0115523. doi: 10.1128/spectrum.01155-23. Epub 2023 May 11. Microbiol Spectr. 2023. PMID: 37166335 Free PMC article.
17 results